Trial Number

465-24

Participant Age Range

18 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

“A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Glofitamab in Combination wtih Gemcitabine Plus Oxaliplatin in Patients from Racial/Ethnic Minorities with Relapsed or Refractory Diffuse Large B-Cell Lymphoma”

The purpose of this study is to test glofitamab in combination with gemcitabine and oxaliplatin, in participants located in the U.S. with relapsed or refractory diffuse large B-cell lymphoma to find out if it is safe, how well it works, and to understand the way your body processes the drug.

Provider

Cancer Institute

Wael A Harb, MD

Medical Oncology
Newport Beach
View Profile

Location

Saddleback Medical Center

24451 Health Center Drive
Laguna Hills
949-837-4500
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Saddleback Medical Center
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.